SOUTH KINGSTOWN — George & Anne Ryan Institute for Neuroscience researchers will investigate reduction of brain blood vessel inflammation in fighting Alzheimer’s disease as part of the $1.3 million, University of Rhode Island-sponsored, BEACON study, the first such clinical trial led and conducted entirely within the state. The Phase 1 clinical trial, mainly funded by…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.